Your browser is no longer supported. Please, upgrade your browser.
Settings
PFE Pfizer Inc. daily Stock Chart
PFE [NYSE]
Pfizer Inc.
IndexDJIA S&P500 P/E17.05 EPS (ttm)2.05 Insider Own0.10% Shs Outstand5.56B Perf Week1.84%
Market Cap193.95B Forward P/E12.41 EPS next Y2.81 Insider Trans-15.56% Shs Float5.53B Perf Month-19.08%
Income11.84B PEG3.60 EPS next Q0.63 Inst Own75.10% Short Float1.23% Perf Quarter-16.96%
Sales53.66B P/S3.61 EPS this Y-11.90% Inst Trans-0.17% Short Ratio2.66 Perf Half Y-17.25%
Book/sh10.71 P/B3.26 EPS next Y-0.64% ROA7.90% Target Price42.82 Perf Year-17.62%
Cash/sh2.32 P/C15.02 EPS next 5Y4.73% ROE20.00% 52W Range33.97 - 46.47 Perf YTD-20.11%
Dividend1.44 P/FCF46.95 EPS past 5Y1.00% ROI10.20% 52W High-24.77% Beta0.68
Dividend %4.13% Quick Ratio1.20 Sales past 5Y0.80% Gross Margin80.10% 52W Low2.91% ATR0.81
Employees92400 Current Ratio1.50 Sales Q/Q-1.50% Oper. Margin23.30% RSI (14)27.53 Volatility1.46% 2.28%
OptionableYes Debt/Eq0.78 EPS Q/Q36.80% Profit Margin23.60% Rel Volume0.47 Prev Close34.87
ShortableYes LT Debt/Eq0.61 EarningsJul 30 BMO Payout62.80% Avg Volume25.56M Price34.96
Recom2.70 SMA20-5.95% SMA50-14.36% SMA200-16.68% Volume7,134,089 Change0.26%
Jul-30-19Downgrade Morgan Stanley Overweight → Equal-Weight $48 → $40
Jul-30-19Downgrade BofA/Merrill Buy → Neutral
Jun-04-19Resumed Morgan Stanley Overweight $48
Feb-20-19Resumed Citigroup Neutral $41
Jan-31-19Upgrade Credit Suisse Neutral → Outperform
Jan-31-19Upgrade Argus Hold → Buy
Jan-23-19Downgrade UBS Buy → Neutral
Dec-11-18Downgrade JP Morgan Overweight → Neutral
Nov-01-18Downgrade BMO Capital Markets Outperform → Market Perform
Jun-08-18Initiated Cantor Fitzgerald Overweight $45
Apr-05-18Downgrade Barclays Overweight → Equal Weight $41 → $38
Jan-29-18Reiterated SunTrust Hold $33 → $40
Sep-20-17Upgrade Morgan Stanley Equal-Weight → Overweight
Jul-20-17Downgrade Credit Suisse Outperform → Neutral
May-16-17Downgrade Citigroup Neutral → Sell
Dec-02-16Initiated Guggenheim Neutral
Nov-02-16Downgrade Argus Buy → Hold
Oct-13-16Downgrade Jefferies Buy → Hold
Jun-20-16Reiterated Jefferies Buy $42 → $40
May-12-16Initiated Berenberg Hold $38
Aug-22-19 10:20AM  Pfizer's Xtandi Label Expansion Filing Gets Priority Review Zacks
10:07AM  Glaxo Submits First Regulatory Application for Daprodustat Zacks
07:30AM  3 Dividend Stocks That Pay Better Than Coca-Cola Motley Fool
Aug-21-19 04:14PM  Pfizer Digs Deeper Into Gene Therapy, Rivaling These Biotech Stocks Investor's Business Daily
04:10PM  Record Stock Buybacks Fueled by Debt and Cash GuruFocus.com
02:00PM  U.S. FDA Grants XTANDI® (enzalutamide) Application Priority Review for the Treatment of Men with Metastatic Hormone-Sensitive Prostate Cancer Business Wire
12:27PM  Pfizer invests $500 million in expanding gene therapy facility Reuters
11:04AM  Teva Launches Generic Version of Mylan's EpiPen for KIds Zacks
10:50AM  AstraZeneca's Imfinzi Fails in Stage IV Lung Cancer Study Zacks
10:01AM  Pfizer invests $500 million in expanding gene therapy facility Reuters
10:00AM  Pfizer to build $500M facility in Sanford, create hundreds of jobs American City Business Journals
10:00AM  Pfizer Invests Half Billion Dollars to Advance State-of-the-Art Gene Therapy Facility in Sanford, North Carolina Business Wire
09:20AM  Trade of the Day: Pfizer Stock Is Flashing Attractive Buy Signals InvestorPlace
08:56AM  Bayer Inks $7.6B Deal to Divest Animal Health Unit to Elanco Zacks
Aug-20-19 06:38PM  Bayer Sells Animal Health Division to Elanco: Now What? Zacks
03:55PM  Dow's 150-point drop led by losses for Dow Inc., American Express stocks MarketWatch
03:11PM  3 Healthcare Stocks to Trade: UNH, JNJ and PFE InvestorPlace
02:48PM  Pfizer-backed cancer treatment innovator SpringWorks eyes $115M IPO American City Business Journals
01:54PM  3 Great Active Mutual Funds for the Current Environment InvestorPlace
01:34PM  Dow Inc., American Express share losses contribute to Dow's nearly 75-point drop MarketWatch
12:02PM  Parents Push One Rare-Disease Drug Through FDA, Not Its Successor Bloomberg
10:45AM  Sarepta Stock Falls as FDA Denies Approval to Golodirsen Zacks
10:09AM  Exelixis (EXEL) Stock Up 15.2% YTD on Strong Cabometyx Sales Zacks
07:00AM  The Pfizer Foundation Invests in 20 Organizations Tackling Infectious Diseases and Antimicrobial Resistance Business Wire
Aug-19-19 02:45PM  Obesity Epidemic Leads To A New Problem And It Could Be Worth Billions Investor's Business Daily
08:58AM  Solid Biosciences Surges on DMD Gene Therapy Study Amendments Zacks
07:58AM  Pfizer (NYSE:PFE) Shareholders Have Enjoyed A 20% Share Price Gain Simply Wall St.
Aug-18-19 06:16PM  52-Week Company Lows GuruFocus.com
Aug-17-19 12:22PM  Market Volatility Got You Nervous? The Merger Fund Might Be the Answer Barrons.com
Aug-16-19 04:25PM  How AbbVie Plans To Take On Pfizer, Lilly And Kick Its Humira Habit Investor's Business Daily
01:35PM  AbbVie Stock Is Poised To Become A Top 5 Pharma But Should You Buy It? Investor's Business Daily
11:28AM  Pharma Stock Roundup: Pipeline/Regulatory Updates From JNJ, LLY, AZN, RHHBY Zacks
Aug-15-19 03:36PM  The Top Pharma Stocks for 2019 Investopedia
02:41PM  Sarepta's Lone Analyst Skeptic Takes On 22 Bulls With Renewed Warnings Bloomberg
01:26PM  Pfizer recalls two lots of migraine drug due to potential bacterial contamination MarketWatch
11:54AM  10 Cheap Dividend Stocks to Load Up On InvestorPlace
07:48AM  Merck's Cancer Immunotherapy Keytruda Continues to Aid Growth Zacks
05:55AM  Bain executive joins biotech startup Cerevel's C-suite American City Business Journals
Aug-14-19 12:18PM  Vaccinex (VCNX) Attains Full Enrollment in Lung Cancer Study Zacks
09:37AM  Deciphera's GIST Drug Succeeds in Pivotal Study, Stock Up 80% Zacks
01:00AM  Germany's Stada is "very selective" on acquisitions, CEO says Reuters
Aug-13-19 02:31PM  Tuesdays Vital Data: Uber, Pfizer and Roku InvestorPlace
08:22AM  3 Big Stock Charts for Tuesday: Centene, Hormel Foods and Advance Auto Parts InvestorPlace
07:27AM  GSK's new pharma president carries Merck, Pfizer experience American City Business Journals
06:00AM  5 Biggest New Drugs Approved in 2019 So Far Motley Fool
Aug-12-19 06:27PM  US Indexes Close Lower Monday With Concerns Over China GuruFocus.com
04:21PM  Dow Jones Today: Doth Thou Protest InvestorPlace
04:05PM  Stocks - Dow Sinks as Trade Jitters, Growth Worries Slam Markets Again Investing.com
01:57PM  Pfizer's stock sinks again, toward 14-month low to pace 'Dow's' losers MarketWatch
12:44PM  Pfizer Stock Is A Top Pharma Company But Should You Buy It? Investor's Business Daily
09:44AM  Amgen Wins Enbrel U.S. Patent Litigation Against Novartis Zacks
09:02AM  Pfizer Falls 3% Investing.com
06:00AM  Merger Talk Boosts Pfizer MoneyShow
05:00AM  5 Big Pharma Showdowns to Watch Barrons.com
12:00AM  Biopharma Tie-Ups and Quebecois Weed Woes Motley Fool
Aug-11-19 11:14PM  52-Week Company Lows GuruFocus.com
Aug-09-19 09:50AM  Pharma Stock Roundup: AGN, NVO Earnings, EU Nod to SNY & ABBV Drugs for New Patients Zacks
Aug-08-19 04:26PM  Sarepta stock tumbles after Duchenne gene therapy complication American City Business Journals
12:56PM  UPDATE 1-Patient in Sarepta gene therapy trial develops serious illness; shares plunge Reuters
10:37AM  Sarepta Stock Is Falling Because Its Lead on Pfizer May Be Shrinking Barrons.com
10:33AM  Sarepta (SRPT) Q2 Loss Widens Y/Y, Golodirsen Nears Approval Zacks
09:25AM  Aerie (AERI) Beats on Q2 Earnings & Sales, Lowers Guidance Zacks
12:06AM  ICU Medical, Inc. (ICUI) Q2 2019 Earnings Call Transcript Motley Fool
Aug-07-19 11:00AM  Conatus (CNAT) Beats on Q2 Earnings, Stops Emricasan Studies Zacks
Aug-06-19 09:30AM  SNY vs. PFE: Which Stock Is the Better Value Option? Zacks
08:19AM  3 Big Stock Charts for Tuesday: Pfizer, AES and Centurylink InvestorPlace
02:29AM  Fear Around Bristol-Myers Squibb Stock is Starting to Fade InvestorPlace
Aug-05-19 03:26PM  The Vanguard Health Care Fund Buys Pfizer, Humana GuruFocus.com
02:09PM  Investors Dont Like Mylans Deal With Pfizer Barrons.com
12:29PM  52-Week Company Lows GuruFocus.com
12:03PM  The Zacks Analyst Blog Highlights: Caterpillar, Walmart, McDonald's, Pfizer and Marsh & McLennan Zacks
08:57AM  Pfizer Falls 3% Investing.com
08:56AM  GlycoMimetics stock down 53% after Phase 3 trial failure MarketWatch
06:34AM  GlycoMimetics Plummets After Phase 3 Trial of Sickle Cell Treatment Fails TheStreet.com
Aug-04-19 09:00AM  These 5 Prescription Drugs Will Generate a Jaw-Dropping $62.3 Billion in 2024 Motley Fool
Aug-03-19 10:25AM  Bulls And Bears Of The Week: Boeing, GM, Pfizer, Starbucks And More Benzinga
01:00AM  Weekly Wrap: Bond-Fund Picks, Reducing Portfolio Risk, and a Rate Cut Morningstar
Aug-02-19 06:49PM  Pfizer Announces Phase 3 Top-Line Results for Rivipansel in Patients with Sickle Cell Disease Experiencing a Vaso-Occlusive Crisis Business Wire
04:14PM  10 Stock Picks That Should Love Lower Interest Rates Kiplinger
03:03PM  Top Analyst Reports for Caterpillar, Walmart & McDonald's Zacks
01:09PM  After Mylan Gets Acquired, Could Teva Be Next? GuruFocus.com
10:52AM  BioMarin (BMRN) Shares Down on Q1 Earnings & Sales Miss Zacks
09:54AM  Pharma Stock Roundup: PFE, MRK, LLY Q2 Earnings, Upjohn-MYL Merger Zacks
09:32AM  Fitch Ratings downgrades Pfizer to A vs. A-plus with negative outlook MarketWatch
09:29AM  Waiting game: Will Mylan merger change local employment? American City Business Journals
07:24AM  GlycoMimetics (GLYC) Q2 2019 Earnings Call Transcript Motley Fool
12:27AM  Best of Lex: your weekly round-up Financial Times
Aug-01-19 11:17AM  GSK, Pfizer complete deal to combine consumer health brands American City Business Journals
10:50AM  Exelixis (EXEL) Q2 Earnings & Sales Beat, Cabometyx Shines Zacks
08:54AM  Is a Beat in Store for Nektar (NKTR) This Earnings Season? Zacks
04:00AM  Cover story: After years of challenges, Mylan looks to chart a different course American City Business Journals
Jul-31-19 08:31PM  Pfizer Inc (PFE) Q2 2019 Earnings Call Transcript Motley Fool
11:18AM  Stocks - Stocks Dive as Fed's Powell Sinks Future Easing Hopes Investing.com
10:01AM  Wednesdays Vital Data: Pfizer, Advanced Micro Devices and Apple InvestorPlace
07:24AM  3 Big Stock Charts for Wednesday: Southern Co, CF Industries Holdings and National-Oilwell Varco InvestorPlace
05:39AM  Pfizer: Downgrade Double-Whammy On Mylan Deal TipRanks
05:01AM  Heres How Pfizer Stock (and Pharma) Stand to Benefit From Mylan Deal InvestorPlace
Jul-30-19 06:39PM  Edited Transcript of PFE earnings conference call or presentation 29-Jul-19 2:30pm GMT Thomson Reuters StreetEvents -6.42%
06:21PM  US Indexes Close Mostly Lower Tuesday GuruFocus.com
04:39PM  US STOCKS-Tech pulls Wall Street lower on Trump trade warning Reuters
Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases under the Lyrica, Chantix/Champix, Eliquis, Ibrance, Sutent, Xalkori, Inlyta, Xtandi, Enbrel, Xeljanz, Eucrisa, BeneFix, Genotropin, and Refacto AF/Xyntha brands. The company also provides consumer healthcare products that comprise over-the-counter medicines, including dietary supplement products under the Centrum, Caltrate, and Emergen-C names; pain management products under the Advil and ThermaCare names; gastrointestinal products under the Nexium 24HR/Nexium Control and Preparation H names; and respiratory and personal care products under the Robitussin, Advil Cold & Sinus, and ChapStick names. In addition, it offers products that would lose or have lost marketing patent protection; branded generic products; generic sterile injectable products; biosimilars; and anti-infectives under the Lipitor, Premarin family, Norvasc, Lyrica, Celebrex, Viagra, Inflectra/Remsima, Zyvox, Vfend, Revatio, Inspra, Medrol, Sulperazon, Fragmin, Tygacil, Nivestim, and Retacrit, Ixifi Infliximab BS names. Further, the company is also involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company, Astellas Pharma US, Inc., and Oncolytics Biotech Inc.; licensing agreement with BionTech AG; strategic alliance with Verily Life Sciences LLC; and collaboration agreements with Pfizer, Merck & Co., Inc., and Eli Lilly & Company, as well as Merck KGaA, Nektar Therapeutics, and Syapse, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DAMELIO FRANK AExecutive Vice PresidentJul 02Sale44.09153,1846,753,385337,392Jul 03 04:06 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentJun 20Sale44.0030,0001,320,00080,094Jun 21 04:08 PM
PFIZER INC10% OwnerMay 13Buy17.0050,000850,0003,249,973May 14 07:34 AM
MACKENZIE ALEXANDER RExecutive Vice PresidentApr 01Sale42.8315,000642,503110,094Apr 02 03:05 PM
JOHNSON RADY AExecutive Vice PresidentMar 15Sale41.138,700357,83159,797Mar 18 06:37 PM
READ IAN CExecutive ChairmanMar 04Sale43.2950,7882,198,4741,639,280Mar 06 04:03 PM
READ IAN CExecutive ChairmanMar 04Sale43.17530,07822,882,7021,109,202Mar 06 04:03 PM
SUSMAN SALLYExecutive Vice PresidentMar 04Sale43.268,725377,444172,094Mar 06 03:29 PM
SUSMAN SALLYExecutive Vice PresidentMar 04Sale43.1463,9982,760,698108,096Mar 06 03:29 PM
Dolsten MikaelPresident R&DMar 04Sale43.5249,0822,136,293289,126Mar 05 04:54 PM
ROGERS DAWNExecutive Vice PresidentMar 04Sale42.9815,002644,79814,920Mar 05 04:55 PM
Dolsten MikaelPresident R&DMar 01Option Exercise31.34106,1913,328,057438,679Mar 05 04:54 PM
Dolsten MikaelPresident R&DMar 01Sale43.56100,4714,376,852338,208Mar 05 04:54 PM
ROGERS DAWNExecutive Vice PresidentFeb 27Option Exercise32.2319,297621,94245,049Mar 01 07:47 PM
SUSMAN SALLYExecutive Vice PresidentFeb 27Option Exercise32.2385,7632,764,141228,743Mar 01 07:47 PM
YOUNG JOHN DGroup PresidentFeb 27Option Exercise32.23154,3744,975,474441,923Mar 01 07:47 PM
GOETTLER MICHAELGroup PresidentFeb 27Option Exercise32.2330,017967,44848,652Mar 01 07:37 PM
Hwang AngelaGroup PresidentFeb 27Option Exercise32.2311,792380,05623,635Mar 01 07:37 PM
JOHNSON RADY AExecutive Vice PresidentFeb 27Option Exercise32.2330,017967,44881,341Mar 01 07:37 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 27Option Exercise32.2364,3222,073,098123,145Mar 01 07:37 PM
Lewis-Hall Freda CExecutive Vice PresidentFeb 27Option Exercise32.2381,4752,625,939416,278Mar 01 07:37 PM
BOURLA ALBERTChief Executive OfficerFeb 27Option Exercise32.2364,3222,073,098331,982Mar 01 07:29 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 27Option Exercise32.2325,729829,246121,743Mar 01 07:29 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 27Option Exercise32.23182,2475,873,821588,177Mar 01 07:29 PM
YOUNG JOHN DGroup PresidentFeb 23Option Exercise21.0343,724919,516312,403Feb 26 07:45 PM
JOHNSON RADY AExecutive Vice PresidentFeb 23Option Exercise21.0318,004378,62461,182Feb 26 07:45 PM
BOURLA ALBERTChief Executive OfficerFeb 23Option Exercise21.0336,008757,248191,438Feb 26 07:45 PM
Lewis-Hall Freda CExecutive Vice PresidentFeb 23Option Exercise21.0387,4491,839,052388,024Feb 26 07:45 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 23Option Exercise21.03185,1853,894,441522,576Feb 26 07:45 PM
SUSMAN SALLYExecutive Vice PresidentFeb 23Option Exercise21.0397,7372,055,409205,833Feb 26 07:46 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 23Option Exercise21.0343,724919,51683,781Feb 26 07:45 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentFeb 23Option Exercise21.0341,615875,163144,164Feb 26 07:10 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 23Option Exercise21.0330,864649,070115,139Feb 26 07:10 PM
ROGERS DAWNExecutive Vice PresidentFeb 23Option Exercise21.0319,290405,66937,638Feb 26 07:10 PM
GOETTLER MICHAELGroup PresidentFeb 23Option Exercise21.0319,290405,66931,507Feb 26 07:11 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 01Sale42.755,000213,75040,057Feb 01 07:21 PM
Dolsten MikaelPresident R&DJan 31Option Exercise29.78125,9683,751,425362,051Feb 01 07:28 PM
LANKLER DOUGLAS MExecutive Vice PresidentJan 30Sale41.1938,8001,598,07145,057Feb 01 07:21 PM
READ IAN CChairman & CEONov 02Option Exercise26.641,100,20129,312,5881,760,958Nov 06 03:46 PM
PFIZER INC10% OwnerOct 15Buy18.0055,5561,000,00822,032,040Oct 17 05:17 PM
Dolsten MikaelPresident R&DSep 13Option Exercise24.56181,7124,462,167234,299Sep 17 04:08 PM